Article
Survivin expression and its clinical significance in pancreatic cancer.
BMC cancer - 4 Oct 2005
Lee Myung Ah, Park Gyeong-sin, Lee Hee-Jung, Jung Ji-Han, Kang Jin-Hyoung, Hong Young Seon, Lee Kyung Shik, Kim Dong-gu, Kim Seung-Nam
Abstract excerpt
BACKGROUND: Survivin, an inhibitor of apoptosis is expressed in several human cancers. Its expression is known to be associated with poor clinical outcome, but not widely studied in pancreatic cancer. We performed this study to determine the survivin expression in pancreatic cancer and its clinical significance as a prognostic factor. METHODS: We performed immunohistochemical staining for survivin, p53, and Bax...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
